Hep C experts reject ‘flawed’ Cochrane review

High-profile gastroenterologists and hepatologists have rejected a Cochrane Review which claims direct acting antivirals do not reduce morbidity or mortality in people with hepatitis C. The Gastroenterological Society of Australia  has labelled the review “flawed” and is urging doctors not to stop prescribing DAAs, seen as the key to eliminating hepatitis C in Australia. The ...

Already a member?

Login to keep reading.

© 2021 the limbic